Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jillian, Faccone"'
Autor:
Chakkarin, Burudpakdee, Aimee M, Near, Jenny, Tse, Jillian, Faccone, Pedro L, Rodriguez, James K, Karichu, Mindy M, Cheng
Publikováno v:
The American journal of managed care. 28(2)
To understand real-world implementation of the updated CDC HIV diagnostic testing algorithm.Retrospective database analysis.Using data from Quest Diagnostics, we identified patients with at least 1 HIV-1/HIV-2 antibody differentiation test (BioRad Ge
Autor:
S. Huo, Ying Zhang, Melissa Hamilton, Brian Stwalley, Flavia Ejzykowicz, Saby George, Jillian Faccone, Trong Kim Le
Publikováno v:
Annals of Oncology. 32:S701-S702
Autor:
Melissa Hamilton, Daniel M. Geynisman, Jillian Faccone, Brian Stwalley, Ying Zhang, Flavia Ejzykowicz, Trong Kim Le, S. Huo
Publikováno v:
Journal of Clinical Oncology. 39:288-288
288 Background: The introduction of second-line (2L) nivolumab (NIVO) in 2015 (CheckMate 025) and first-line (1L) NIVO plus ipilimumab (NIVO+IPI) in 2018 (CheckMate 214) revolutionized the management of mRCC in the US. This study sought to leverage r
Autor:
Ying Zhang, Flavia Ejzykowicz, Brian Stwalley, Trong Kim Le, Melissa Hamilton, Saby George, S. Huo, Jillian Faccone
Publikováno v:
Journal of Clinical Oncology. 39:286-286
286 Background: RCC accounts for ~80%‒90% of all kidney cancers worldwide. The mRCC treatment landscape is rapidly changing with the approval of new therapies; data describing real-world (RW) treatment patterns and sequencing are limited. This stud
Autor:
James Karichu, Nicole Robinson, Aimee Near, Chakkarin Burudpakdee, Jillian Faccone, Jenny Tse, Pedro L. Rodriguez, Mindy M. Cheng
Publikováno v:
Open Forum Infectious Diseases
Background Current HIV diagnostic laboratory testing guidelines from the US Centers for Disease Control and Prevention (CDC) recommend a sequence of tests for detection, differentiation, and confirmation of HIV-1 and HIV-2 diagnosis. There is a gap i